Analysts’ Updated EPS Estimates for April 7th (ABEV, ARHS, ARVN, AVXL, BEAM, BOXL, COOK, CRDL, DGXX, DKNG)

Analysts’ updated eps estimates for Monday, April 7th:

Ambev (NYSE:ABEV) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating.

Arhaus (NASDAQ:ARHS) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating. The firm currently has $8.50 target price on the stock, down from their previous target price of $13.00.

Arvinas (NASDAQ:ARVN) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $81.00 price target on the stock.

Anavex Life Sciences (NASDAQ:AVXL) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $46.00 price target on the stock.

Anavex Life Sciences (NASDAQ:AVXL) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $42.00 target price on the stock.

Beam Therapeutics (NASDAQ:BEAM) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $80.00 price target on the stock.

Boxlight (NASDAQ:BOXL) had its hold rating reiterated by analysts at Maxim Group.

Traeger (NYSE:COOK) had its market perform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $2.50 target price on the stock.

Cardiol Therapeutics (NASDAQ:CRDL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.00 target price on the stock.

Digihost Technology (NASDAQ:DGXX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $2.50 target price on the stock.

DraftKings (NASDAQ:DKNG) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $65.00 target price on the stock.

DigitalOcean (NYSE:DOCN) had its hold rating reiterated by analysts at Needham & Company LLC.

East West Bancorp (NASDAQ:EWBC) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating. Morgan Stanley currently has $90.00 target price on the stock, down from their previous target price of $118.00.

Gerdau (NYSE:GGB) had its neutral rating reiterated by analysts at Bank of America Co..

International Money Express (NASDAQ:IMXI) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $20.00 price target on the stock.

Ingredion (NYSE:INGR) had its neutral rating reiterated by analysts at UBS Group AG. The firm currently has a $145.00 price target on the stock.

Jefferies Financial Group (NYSE:JEF) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating. Morgan Stanley currently has $41.00 price target on the stock, down from their previous price target of $75.00.

KKR Real Estate Finance Trust (NYSE:KREF) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. They currently have $10.75 price target on the stock.

Lazard (NYSE:LAZ) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. They currently have $33.00 target price on the stock, down from their previous target price of $56.00.

LiqTech International (NASDAQ:LIQT) had its buy rating reissued by analysts at Ascendiant Capital Markets. The firm currently has a $3.40 target price on the stock, up from their previous target price of $3.20.

LyondellBasell Industries (NYSE:LYB) had its sell rating reissued by analysts at UBS Group AG. The firm currently has a $51.00 target price on the stock, down from their previous target price of $76.00.

Navitas Semiconductor (NASDAQ:NVTS) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. The firm currently has $1.50 price target on the stock, down from their previous price target of $2.10.

OPKO Health (NASDAQ:OPK) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $3.00 target price on the stock.

OS Therapies (NYSE:OSTX) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $20.00 target price on the stock.

Prologis (NYSE:PLD) had its sector underperform rating reaffirmed by analysts at Scotiabank. The firm currently has a $97.00 target price on the stock, down from their previous target price of $133.00.

Portillo’s (NASDAQ:PTLO) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $12.00 target price on the stock, down from their previous target price of $15.00.

Q2 (NYSE:QTWO) had its neutral rating reissued by analysts at Compass Point. Compass Point currently has a $60.00 target price on the stock.

Starbucks (NASDAQ:SBUX) had its neutral rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $85.00 price target on the stock, down from their previous price target of $114.00.

Sangamo Therapeutics (NASDAQ:SGMO) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $10.00 target price on the stock.

Sonnet BioTherapeutics (NASDAQ:SONN) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $20.00 price target on the stock.

Sony Group (NYSE:SONY) had its peer perform rating reissued by analysts at Wolfe Research.

STERIS (NYSE:STE) had its hold rating reiterated by analysts at Needham & Company LLC.

Synchrony Financial (NYSE:SYF) had its equal weight rating reissued by analysts at Morgan Stanley. They currently have a $44.00 price target on the stock, down from their previous price target of $82.00.

Target (NYSE:TGT) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating. They currently have $110.00 price target on the stock.

Tower Semiconductor (NASDAQ:TSEM) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $60.00 target price on the stock.

Ternium (NYSE:TX) had its underperform rating reissued by analysts at Bank of America Co.. They currently have a $25.00 target price on the stock.

Udemy (NASDAQ:UDMY) had its hold rating reaffirmed by analysts at Truist Financial Co.. They currently have a $7.00 price target on the stock, down from their previous price target of $10.00.